2021 MIPS Measure #435: Quality of Life Assessment For Patients With Primary Headache Disorders 

Measure Type High Priority Measure? Collection Type(s)
Patient Reported Outcome yes Medicare Part B Claims, MIPS CQM

 

Measure Description

Percentage of patients with a diagnosis of primary headache disorder whose health related quality of life (HRQoL) was assessed with a tool(s) during at least two visits during the 12 month measurement period AND whose health related quality of life score stayed the same or improved

Instructions

This measure is to be submitted at least once per performance period for patients with a diagnosis of primary headache during the performance period. This measure may be submitted by Merit-based Incentive Payment System (MIPS) eligible clinicians who perform the quality actions described in the measure based on the services provided and the measure-specific denominator coding.

Measure Submission Type:

Measure data may be submitted by individual MIPS eligible clinicians, groups, or third party intermediaries. The listed denominator criteria are used to identify the intended patient population. The numerator options included in this specification are used to submit the quality actions as allowed by the measure. The quality-data codes listed do not need to be submitted by MIPS eligible clinicians, groups, or third party intermediaries that utilize this modality for submissions; however, these codes may be submitted for those third party intermediaries that utilize Medicare Part B claims data. For more information regarding Application Programming Interface (API), please refer to the Quality Payment Program (QPP) website.

Denominator

All patients with a diagnosis of primary headache disorder

Denominator Instructions:Primary Headache for the purpose of this measure includes the following types of headache:

  • Migraine: Migraine without aura, migraine with aura, childhood periodic syndromes that are commonly precursors of migraine, retinal migraine, complications of migraine, probable migraine.
  • Tension-Type Headache (TTH): Infrequent episodic TTH, frequent episodic TTH, chronic TTH, probable TTH.
  • Cluster Headache (CH) and Other Trigeminal Autonomic Cephalgias: Cluster headache, paroxysmal hemicrania, short-lasting unilateral neuralgia form headache attacks with conjunctival injection and tearing (SUNCT), probable trigeminal autonomic cephalgia.
  • Other Primary Headaches: Primary stabbing headache, primary cough headache, primary exertional headache, primary headache associated with sexual activity, hypnic headache, primary thunderclap headache, hemicrania continua, new daily-persistent headache.

DENOMINATOR NOTE: *Signifies that this CPT Category I code is a non-covered service under the Medicare Part B Physician Fee Schedule (PFS). These non-covered services should be counted in the denominator population for MIPS CQMs.

Denominator Criteria (Eligible Cases):

Diagnosis for Primary Headache (ICD-10-CM): G43.001, G43.009, G43.011, G43.019, G43.101, G43.109, G43.111, G43.119, G43.401, G43.409, G43.411, G43.419, G43.501, G43.509, G43.511, G43.519, G43.601, G43.609, G43.611, G43.619,G43.701, G43.709, G43.711, G43.719, G43.801, G43.809, G43.811, G43.819, G43.821, G43.829, G43.831,G43.839, G43.901, G43.909, G43.911, G43.919, G44.009, G44.019, G44.029, G44.039, G44.049, G44.059, G44.099, G44.1, G44.209, G44.219, G44.221, G44.229, G44.51, G44.52, G44.53, G44.59, G44.81, G44.82, G44.83, G44.84, G44.85, G44.89

AND

Encounter during the performance period (CPT): 99201, 99202, 99203, 99204, 99205, 99211, 99212, 99213, 99214, 99215, 99241*, 99242*, 99243*, 99244*, 99245*

WITHOUT

Telehealth Modifier: GQ, GT, 95, POS 02

AND

At Least Two Visits during the Performance Period

Numerator

Patient whose health related quality of life was assessed with a tool(s) during at least two visits during the 12 month measurement period AND whose health related quality of life score stayed the same or improved

Numerator Instructions:List quality of life (QoL) tools: Migraine Disability Assessment (MIDAS) and PedMIDAS(proprietary); Headache Impact Test-6 (HIT-6)(proprietary); Migraine Specific Quality of Life Tool (MSQ); Neck Disability Index (NDI)-used for cervicogenic headaches; McGill Questionnaire.Timing Between Visits: Must be separated by at least 90 days for MIDAS and at least 4 weeks for any other tool.See specific tools for scoring methods related to improvement or stayed the same: Each tool defines improvement differently based on their scoring methodology. For example, when using the MIDAS improvement would be indicated by reduction in MIDAS disability grade and in the HIT-6 a reduction in the number of days with disability overtime indicates improvement.

NUMERATOR NOTE: The two assessments must be separated by at least 90 days for MIDAS and at least 4 weeks for any other tool. It is expected that the QoL score or ranking will stay the same or improve in order for this measure to be successfully completed. Denominator Exception(s) are determined on the date of the denominator eligible encounter.

Numerator Options:

Performance Met:

Health-related quality of life assessed with tool during at least two visits and quality of life score remained the same or improved (G9634)

OR

Denominator Exception:

Health-related quality of life not assessed with tool for documented reason(s) (e.g., patient has a cognitive or neuropsychiatric impairment that impairs his/her ability to complete the HRQoL survey, patient has the inability to read and/or write in order to complete the HRQoL questionnaire) (G9635)

OR

Performance Not Met:

Health-related quality of life not assessed with tool during at least two visits or quality of life score declined (G9636)


Tags

CMS-Neurology-2021, ENT/Otolaryngology-2021, General Practice/Family Medicine-2021, Geriatrics / Gerontology-2021, Internal Medicine-2021, Neurology-2021, Neuromusculoskeletal Medicine-2021, Neurosurgery-2021, NonTelehealth-2021, Occupational Therapy-2021, Pain Management-2021, Pediatrics-2021, Physical Medicine-2021, Quality-2021, Sleep Medicine-2021